StockData
aTYR PHARMA INC logo

aTYR PHARMA INC (ATYR) stock

ATYRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$4.99−0.25 (-4.77%)

Close on Nov 17, 2026Market cap $489.46MP/E –Yield –

aTYR PHARMA enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

aTYR PHARMA's enterprise value was -$41.01M on Nov 11, 2026, against -$8.86M a year earlier. Over the last 5 years it ranged from -$83.42M to $419.11M, with a median of -$2.42M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$41.01M–
2025Dec 31, 2025-$83.42M-140.1%
2024Dec 31, 2024$208.26M–
2023Dec 29, 2023-$19.75M–
2022Dec 30, 2022-$14.02M-115.4%
2021Dec 31, 2021$91.07M+1550.7%
2020Dec 31, 2020$5.52M–
2019Dec 31, 2019-$11.26M–
2018Dec 31, 2018-$23.22M-181.9%
2017Dec 29, 2017$28.37M–
2016Dec 30, 2016-$19.54M-115.8%
2015Dec 31, 2015$123.57M–

More aTYR PHARMA figures

See a number that looks wrong?